EPISODE · May 12, 2026 · 1 MIN
Teleflex Q1: Revenue Surges, Margins Dip, Divestitures & New CEO
from The Daily News Now! Business
Teleflexs Q1 2026 earnings soared, with $548.3M revenue, a 32.3% YoY increase, and $1.39 EPS, 14% above estimates. Growth came from Vascular Intervention acquisition and strong sales, but integration issues and recalls hurt margins. Shares surged on news, with investors liking the portfolio shift to high-growth areas. Teleflex plans to divest acute care, urology, and OEM units, freeing up $1.8B for buybacks and debt cuts. New CEO Jason Weidman and R&D bets like Freesolve scaffold trials aim to boost margins back to 23% by mid-2028. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/5dcaf6e83fb6ea31
NOW PLAYING
Teleflex Q1: Revenue Surges, Margins Dip, Divestitures & New CEO
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m